These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8004232)

  • 1. Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations.
    Napoli KL; Kahan BD
    J Chromatogr B Biomed Appl; 1994 Mar; 654(1):111-20. PubMed ID: 8004232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of rapamycin in whole blood by HPLC.
    Svensson JO; Brattström C; Säwe J
    Ther Drug Monit; 1997 Feb; 19(1):112-6. PubMed ID: 9029760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic benzamide and anilide derivatives as high-performance liquid chromatography internal standards: application to sirolimus (rapamycin) determination.
    Ferron GM; Conway WD; Jusko WJ
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):243-51. PubMed ID: 9448082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection.
    Napoli KL; Kahan BD
    Clin Chem; 1996 Dec; 42(12):1943-8. PubMed ID: 8969630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry.
    Streit F; Christians U; Schiebel HM; Napoli KL; Ernst L; Linck A; Kahan BD; Sewing KF
    Clin Chem; 1996 Sep; 42(9):1417-25. PubMed ID: 8787698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic monitoring of sirolimus in human whole-blood samples by high-performance liquid chromatography.
    Maleki S; Graves S; Becker S; Horwatt R; Hicks D; Stroshane RM; Kincaid H
    Clin Ther; 2000; 22 Suppl B():B25-37. PubMed ID: 10823371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioreceptor assay for sirolimus.
    Goodyear N; Napoli KL; Murthy JN; Kahan BD; Soldin SJ
    Clin Biochem; 1996 Oct; 29(5):457-60. PubMed ID: 8884067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection.
    Cattaneo D; Perico N; Gaspari F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jul; 774(2):187-94. PubMed ID: 12076688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatographic method for the determination of sirolimus in blood using electrochemical detection.
    Mochizuki N; Suka E; Matsumoto K; Akimoto O; Ohno K; Shimamura T; Furukawa H; Todo S; Kishino S
    Biomed Chromatogr; 2009 Mar; 23(3):267-72. PubMed ID: 18814192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of rapamycin in whole blood using reverse-phase high-performance liquid chromatography.
    Yatscoff RW; Faraci C; Bolingbroke P
    Ther Drug Monit; 1992 Apr; 14(2):138-41. PubMed ID: 1585399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedure for determination of immunosuppressive drugs in whole blood with liquid chromatography-isotope dilution mass spectrometry.
    Molnár PM; Dux L; Reinauer H; Kress M; Akerboom T; Szederkényi E; Kaiser P
    Clin Lab; 2011; 57(11-12):983-92. PubMed ID: 22239031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.
    Yatscoff RW; Wang P; Chan K; Hicks D; Zimmerman J
    Ther Drug Monit; 1995 Dec; 17(6):666-71. PubMed ID: 8588238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of sirolimus in kidney transplant patients.
    Ferron GM; Mishina EV; Zimmerman JJ; Jusko WJ
    Clin Pharmacol Ther; 1997 Apr; 61(4):416-28. PubMed ID: 9129559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of rapamycin.
    Yatscoff RW
    Transplant Proc; 1996 Apr; 28(2):970-3. PubMed ID: 8623483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of cyclosporin A in human and mouse plasma by reversed-phase high-performance liquid chromatography.
    Bardelmeijer HA; Ouwehand M; Beijnen JH; Schellens JH; van Tellingen O
    J Chromatogr B Biomed Sci Appl; 2001 Nov; 763(1-2):201-6. PubMed ID: 11710579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
    Yatscoff RW; LeGatt DF; Kneteman NM
    Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study.
    Li JL; Wang XD; Wang CX; Fu Q; Liu LS; Huang M; Zhou SF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):111-8. PubMed ID: 18417431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatography of rapamycin.
    Napoli KL; Kahan BD
    Clin Chem; 1991 Feb; 37(2):294-5. PubMed ID: 1993346
    [No Abstract]   [Full Text] [Related]  

  • 19. High-throughput semi-automated 96-well liquid/liquid extraction and liquid chromatography/mass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole blood.
    Brignol N; McMahon LM; Luo S; Tse FL
    Rapid Commun Mass Spectrom; 2001; 15(12):898-907. PubMed ID: 11400194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific method for the measurement of cyclosporin A in human whole blood by liquid chromatography-tandem mass spectrometry.
    Simpson J; Zhang Q; Ozaeta P; Aboleneen H
    Ther Drug Monit; 1998 Jun; 20(3):294-300. PubMed ID: 9631926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.